The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017–2021
Open accessAbstract
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. Between 2017 and 2021, the average annual age-adjusted incidence rate (AAAIR) of all primary malignant and non-malignant brain and other CNS tumors was 25.34 per 100,000 population (malignant AAAIR=6.89 and non-malignant AAAIR=18.46). This overall rate was higher in females compared to males (28.77 versus 21.78 per 100,000) and non-Hispanic Black persons compared to persons who were non-Hispanic White (26.60 versus 25.72 per 100,000), non-Hispanic American Indian/Alaska Native (23.48 per 100,000), non-Hispanic Asian or Pacific Islander (19.86 per 100,000), and Hispanic persons of all races (22.37 per 100,000). Gliomas accounted for 22.9% of all tumors. The most commonly occurring malignant brain and other CNS histopathology was glioblastoma (13.9% of all tumors and 51.5% of all malignant tumors), and the most common predominantly non-malignant histopathology was meningioma (41.7% of all tumors and 56.8% of all non-malignant tumors). Glioblastomas were more common in males, and meningiomas were more common in females. In children and adolescents (ages 0-19 years), the incidence rate of all primary brain and other CNS tumors was 6.02 per 100,000 population. There were 87,053 deaths attributed to malignant brain and other CNS tumors between 2017 and 2021. This represents an average annual mortality rate of 4.41 per 100,000 population and an average of 17,411 deaths per year. The five-year relative survival rate following diagnosis of a malignant brain or other CNS tumor was 35.7%. For a non-malignant brain or other CNS tumor the five-year relative survival rate was 92.0%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Self-citationPermutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Simple Features for R: Standardized Support for Spatial Vector Data
Pebesma, E. (2018) · The R Journal · doi:10.32614/rj-2018-009 · Cited by 4,701
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,442
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
The epidemiology of glioma in adults: a "state of the science" review
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou087 · Cited by 2,220
Self-citationOstrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Self-citationThe New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac202 · Cited by 1,565
Self-citationOstrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad149 · Cited by 1,294
Self-citationEpidemiology and etiology of meningioma
Wiemels, J., Wrensch, M., & Claus, E. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0386-3 · Cited by 1,226
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Ostrom, Q. T., Cote, D. J., Ascha, M., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1789 · Cited by 614
Self-citationAge standardization of death rates: implementation of the year 2000 standard.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 612
van den Bent, M. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0725-7 · Cited by 577
Efficient interval estimation for age-adjusted cancer rates
Tiwari, R. C., Clegg, L. X., & Zou, Z. (2006) · Statistical Methods in Medical Research · doi:10.1177/0962280206070621 · Cited by 566
Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review
Johnson, K. J., Cullen, J., Barnholtz-Sloan, J. S., Ostrom, Q. T., Langer, C. E., Turner, M. C., McKean-Cowdin, R., Fisher, J. L., Lupo, P. J., Partap, S., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0207 · Cited by 393
Self-citationOstrom, Q. T., Price, M., Ryan, K., Edelson, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac161 · Cited by 321
Self-citationRisk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
Self-citationImpact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Females have the survival advantage in glioblastoma
Ostrom, Q. T., Rubin, J. B., Lathia, J. D., Berens, M. E., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy002 · Cited by 192
Self-citationCancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System
Zullig, L. L., Jackson, G. L., Dorn, R. A., Provenzale, D. T., McNeil, R., Thomas, C. M., & Kelley, M. J. (2012) · Military Medicine · doi:10.7205/milmed-d-11-00434 · Cited by 183
Aldape, K., Simmons, M. L., Davis, R. L., Miike, R., Wiencke, J., Barger, G., Lee, M., Chen, P., & Wrensch, M. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2342::aid-cncr19>3.0.co;2-x · Cited by 164
Weir, H. K., Johnson, C. J., Mariotto, A. B., Turner, D., Wilson, R. J., Nishri, D., & Ward, K. C. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu018 · Cited by 82
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma
Gittleman, H. R., Ostrom, Q. T., Stetson, L. C., Waite, K. A., Hodges, T. R., Wright, C. H., Wright, J. M., III, Rubin, J. B., Berens, M. E., Lathia, J. D., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz019 · Cited by 75
Self-citationIorgulescu, J. B., Sun, C., Neff, C., Cioffi, G., Gutierrez, C., Kruchko, C. A., Ruhl, J., Waite, K. A., Negoita, S., Hofferkamp, J., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac113 · Cited by 75
Self-citationKruchko, C., Ostrom, Q. T., Gittleman, H. R., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy006 · Cited by 68
Self-citationModeling Reporting Delays and Reporting Corrections in Cancer Registry Data
Midthune, D. N., Fay, M. P., Clegg, L. X., & Feuer, E. J. (2005) · Journal of the American Statistical Association · doi:10.1198/016214504000001899 · Cited by 65
Consensus Conference on Brain Tumor Definition for Registration
McCarthy, B. J., Surawicz, T. S., Bruner, J. M., et al. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.2.134 · Cited by 62
Predicting US‐ and state‐level cancer counts for the current calendar year
Zhu, L., Pickle, L. W., Ghosh, K., Naishadham, D., Portier, K. M., Chen, H., Kim, H., Zou, Z., Cucinelli, J. E., Kohler, B., et al. (2012) · Cancer · doi:10.1002/cncr.27405 · Cited by 58
Report of the Second Workshop on Age Adjustment.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 41
Consensus Conference on Brain Tumor Definition for Registration
McCarthy, B. J. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-2-134 · Cited by 39
Ostrom, Q. T., Gittleman, H. R., Kruchko, C., Louis, D. N., Brat, D. J., Gilbert, M. R., Petkov, V. I., & Barnholtz‐Sloan, J. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2217-7 · Cited by 37
Self-citationForjaz, G., Barnholtz‐Sloan, J. S., Kruchko, C., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa175 · Cited by 36
Self-citationLym, R. L., Ostrom, Q. T., Kruchko, C., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1775-4 · Cited by 26
Self-citationPilocytic astrocytoma: Where do they belong in cancer reporting?
Ostrom, Q. T., Kruchko, C., & Barnholtz‐Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz202 · Cited by 23
Self-citationKruchko, C., Gittleman, H. R., Ruhl, J., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz029 · Cited by 21
Self-citationWilson, R. J., O’Neil, M. E., Ntekop, E., et al. (2014) · PubMed · Cited by 20
Waite, K. A., Cioffi, G., Kruchko, C., et al. (2022) · Neuro-Oncology Practice · doi:10.1093/nop/npac025 · Cited by 16
Self-citationData comparability and quality.
Bray, F., Kohler, B., & Ferlay, J. (2014) · PubMed · Cited by 13
Ostrom, Q. T., Kruchko, C., Neff, C., et al. (2022) · PubMed · Cited by 4
Self-citation
Metadata
- Authors
- Price, M., Ballard, C., Benedetti, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., Barnholtz-Sloan, J. S., & Ostrom, Q. T.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-10
- Volume
- 26
- Issue
- Supplement_6
- Pages
- vi1-vi85
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W4403197275
- Cited by
- 526
- References
- 43
- FWCI
- 122.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.